Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beisi Xu

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Nature Communications|December 11, 2021
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastomaAlexandra D'Oto, Jie Fang, Hongjian Jin, et al.
The Journal of Clinical Investigation|February 9, 2023
PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophagesWinson S Ho, Isha Mondal, Beisi Xu, et al.
Cell Reports|March 8, 2018
Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid CulturesLu Wang, Daniel Hiler, Beisi Xu, et al.
Science Advances|January 6, 2023
ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasisRuishan Wang, Akshita B Bhatt, Benjamin A Minden-Birkenmaier, et al.
The Journal of Experimental Medicine|June 27, 2024
Dynamic Foxp3-chromatin interaction controls tunable Treg cell functionMinghong He, Xinying Zong, Beisi Xu, et al.
Developmental Cell|January 3, 2025
Latent epigenetic programs in Müller glia contribute to stress and disease response in the retinaJackie L Norrie, Marybeth S Lupo, Danielle R Little, et al.
Cancer Discovery|December 30, 2017
<i>MYC</i> Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer AmplificationMark W Zimmerman, Yu Liu, Shuning He, et al.
Blood Cancer Discovery|March 5, 2022
ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute LeukemiaKirsten M Dickerson, Chunxu Qu, Qingsong Gao, et al.
Science (New York, N.Y.)|November 6, 2025
Direct targeting and regulation of RNA polymerase II by cell signaling kinasesPreeti Dabas, Meritxell B Cutrona, Wojciech Rosikiewicz, et al.
The Journal of Experimental Medicine|June 4, 2021
Foxp3 enhancers synergize to maximize regulatory T cell suppressive capacityXinying Zong, Xiaolei Hao, Beisi Xu, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Nature Communications|December 11, 2021
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastomaAlexandra D'Oto, Jie Fang, Hongjian Jin, et al.
The Journal of Clinical Investigation|February 9, 2023
PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophagesWinson S Ho, Isha Mondal, Beisi Xu, et al.
Cell Reports|March 8, 2018
Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid CulturesLu Wang, Daniel Hiler, Beisi Xu, et al.
Science Advances|January 6, 2023
ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasisRuishan Wang, Akshita B Bhatt, Benjamin A Minden-Birkenmaier, et al.
The Journal of Experimental Medicine|June 27, 2024
Dynamic Foxp3-chromatin interaction controls tunable Treg cell functionMinghong He, Xinying Zong, Beisi Xu, et al.
Developmental Cell|January 3, 2025
Latent epigenetic programs in Müller glia contribute to stress and disease response in the retinaJackie L Norrie, Marybeth S Lupo, Danielle R Little, et al.
Cancer Discovery|December 30, 2017
<i>MYC</i> Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer AmplificationMark W Zimmerman, Yu Liu, Shuning He, et al.
Blood Cancer Discovery|March 5, 2022
ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute LeukemiaKirsten M Dickerson, Chunxu Qu, Qingsong Gao, et al.
Science (New York, N.Y.)|November 6, 2025
Direct targeting and regulation of RNA polymerase II by cell signaling kinasesPreeti Dabas, Meritxell B Cutrona, Wojciech Rosikiewicz, et al.
The Journal of Experimental Medicine|June 4, 2021
Foxp3 enhancers synergize to maximize regulatory T cell suppressive capacityXinying Zong, Xiaolei Hao, Beisi Xu, et al.
Pageof 11